Cortesi, P. A. (2019) “The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis”, Farmeconomia. Health economics and therapeutic pathways, 20(1). doi: 10.7175/fe.v20i1.1435.